En este sentido, no se trata nicamente de cunto aumenta la glucosa, sino de cmo el organismo gestiona ese aumento (2,4,5)
OTA can lead to kidney disease and adverse neurological effects
Glutamate release by primary brain tumors induces epileptic activity
Antithrombotic Effects GLP-1 agonists reduce cardiovascular events through several mechanisms previously summarized to include improved glycemic control, weight loss, lowering blood pressure, lipid lowering, reduced atherogenesis, attenuated vascular inflammation, improved endothelial cell function, vasodilation, and direct cardiovascular protective effects [88, 89]
PlexusDx explains what current evidence tells us about combining these two substances